Episodes
Friday Oct 30, 2015
Taking a CHANCE on Clopidogrel Plus Aspirin to Prevent Stroke Recurrence
Friday Oct 30, 2015
Friday Oct 30, 2015
The CHANCE (Clopidogrel in High risk patients with Acute Non-disabling Cerebrovascular Events) trial investigators examine whether patients who have a TIA or mini-stroke should receive aspirin AND clopidogrel to reduce the risk of recurrent stroke.
Friday Oct 16, 2015
How Long Is Long Enough? Extending OAC After Unprovoked PE
Friday Oct 16, 2015
Friday Oct 16, 2015
The recommended treatment duration for a first episode of unprovoked venous thromboembolism (VTE) is, at a minimum, 3 months with extended anticoagulation favored for those who are not at high risk for bleeding. However, the optimal duration of anticoagulation therapy remains unknown. The Prolonged Anticoagulation Treatment for a First Episode of Idiopathic Pulmonary Embolism (PADIS-PE) study examines this question but, most importantly, provides insights about patient outcomes after anticoagulation treatment is discontinued